Pancreatic Cancer Research

ResearcherUniversity of LiverpoolNo recent work listed

Victoria E. Shaw

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0429-0186; OpenAlex author ID A5059419654. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2013: 1 paper · 2014: 3 papers · 2015: none · 2016: 3 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 8

  1. Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation. Co-author DOI 10.3390/cimb45030164↗
  2. Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/bjc.2015.468↗
  3. miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer. Co-author DOI 10.1080/2162402x.2016.1160181↗
  4. Activated Schwann cells in pancreatic cancer are linked to analgesia via suppression of spinal astroglia and microglia. Co-author DOI 10.1136/gutjnl-2015-309784↗
  5. The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patie… First author DOI 10.1007/s00262-013-1502-y↗
  6. Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an … Co-author DOI 10.1016/s1470-2045(14)70236-0↗
  7. Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease. Co-author DOI 10.1186/1476-4598-13-114↗
  8. iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance. Co-author DOI 10.1038/bjc.2013.150↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eithne Costello · 7 shared papers, 2013–2023 · strength 0.45
  2. William Greenhalf · 5 shared papers, 2013–2023 · strength 0.35
  3. John P. Neoptolemos · 5 shared papers, 2013–2016 · strength 0.20
  4. Karen Aughton · 1 shared paper, 2023 · strength 0.18
  5. Robert Ferguson · 1 shared paper, 2023 · strength 0.18
  6. Gary Middleton · 3 shared papers, 2014–2016 · strength 0.13
  7. Helmut Friess · 2 shared papers, 2013–2016 · strength 0.08
  8. Claire Jenkinson · 2 shared papers, 2013–2014 · strength 0.07
  9. David Cunningham · 2 shared papers, 2014 · strength 0.07
  10. Juan W. Valle · 2 shared papers, 2014 · strength 0.07
  11. Pippa G. Corrie · 2 shared papers, 2014 · strength 0.07
  12. Paula Ghaneh · 1 shared paper, 2016 · strength 0.06
  13. Daniel H. Palmer · 1 shared paper, 2016 · strength 0.06
  14. Leonie Mühlberg · 1 shared paper, 2016 · strength 0.05
  15. Marvin Schober · 1 shared paper, 2016 · strength 0.05
  16. Magdalena Huber · 1 shared paper, 2016 · strength 0.05
  17. Bence Sipos · 1 shared paper, 2016 · strength 0.05
  18. Heidi Griesmann · 1 shared paper, 2016 · strength 0.05
  19. Sebastian Krug · 1 shared paper, 2016 · strength 0.05
  20. Patrick Michl · 1 shared paper, 2016 · strength 0.05
  21. Thomas Mathias Gress · 1 shared paper, 2016 · strength 0.05
  22. Elke Tieftrunk · 1 shared paper, 2016 · strength 0.05
  23. Paulo Leonardo Pfitzinger · 1 shared paper, 2016 · strength 0.05
  24. Sonja M. Wörmann · 1 shared paper, 2016 · strength 0.05
  25. Stephan Schorn · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.